2 results for author: Sarah Motley


Medicines – In Support of Follow-On Innovation

25 Sep 2018 In a recent article Professor Christopher Holman (University of Missouri - Kansas City School of Law) again comes out in support of patent protection for the embodiment of follow-on innovation in medicines (Christopher M. Holman, “Inside views: Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection”, Intellectual Property Watch, 21 September 2018). Follow-on pharmaceutical innovation seeks to improve upon existing medicines by a range of alternatives such as offering a safer and more effective variation than the original product or creating a more patient- and treatment-friendly formulation. Despite its ...

Joint submission to the SPC on Post Filing data – February 2018

INTERPAT & IPO have submitted a white paper on the Determination of Experimental Post Filing Data. Click on the links below to read the submission: On the Determination of Post-Filing Experimental Data latest version Appendix File_On the Determination of Post-Filing Experimental Data.revised1